-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
LAVA Therapeutics NV quarterly/annual Costs and Expenses history and growth rate from Q1 2024 to Q2 2025.
- LAVA Therapeutics NV Costs and Expenses for the quarter ending June 30, 2025 was $7.29M, a 22.4% decline year-over-year.
- LAVA Therapeutics NV annual Costs and Expenses for 2024 was $41.7M, a 16.9% decline from 2023.
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)